Dabigo 110 mg
| SKU | 2635 |
|---|---|
| Generic For | Pradaxa |
| Manufacturer | MSN Laboratories Ltd |
| Active Ingredient | Dabigatran Etexilate |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Capsule/s | US$ 0.73 | US$ 21.90 | |||
|
|||||
| 60 Capsule/s | US$ 0.50 | US$ 30.0032%US$ 43.80 | |||
|
|||||
| 90 Capsule/s | US$ 0.50 | US$ 45.0032%US$ 65.70 | |||
|
|||||
Dabigo 110mg (Dabigatran Etexilate) – Affordable Pradaxa Alternative
Dabigo 110mg capsule is a prescription medicine for treating patients with atrial fibrillation (irregular heart rhythm). This medication contains the active ingredient Dabigatran Etexilate, a class of anticoagulants or blood thinners. It is used in adults to treat the following conditions:
- Prevent blood clots in the veins post-knee or hip replacement surgery.
- Prevent blood clots in the brain and the heart if you are suffering from a type of irregular heart rhythm.
- Treat blood clots in the veins of your lungs and legs, and prevent their recurrence.
- Reduces the risk of heart attack, stroke or thrombosis.
Taking Dabigo 110mg capsules for the prescribed period helps prevent health complications from blood clots. However, it doesn’t dissolve blood clots; it prevents them from getting bigger in the body, enabling them to dissolve over time and preventing new ones from forming.
The dabigatran etexilate capsule dosage and treatment duration vary from patient to patient based on the severity of the condition. Following the prescribed dosage schedule helps achieve the desired results.
What precautions should be taken of Dabigo 110mg ?
Take special precautions if you have surgery: In this case, Dabigo 110mg will need to be stopped temporarily due to increased bleeding risk during and after surgery. Make sure you follow your doctor’s advice and take Dabigo capsules as instructed before and after the operation. If you have an injury during the treatment, especially if you hit your head, please seek immediate medical help. You should talk to your doctor, as you may be more likely to have bleeding.
What are the side effects of Dabigo 110mg?
Dabigo 110mg affects blood clotting, so most side effects are related to signs such as bruising or bleeding. Severe bleeding may occur; consult your doctor immediately if you develop any bleeding event that does not stop or experience signs of excessive bleeding such as weakness, paleness, headache, tiredness, dizziness, or unexplained swelling.
How to use Dabigo 110mg
Take Dabigo 110mg capsules exactly as your doctor has told you. The recommended dose is two capsules of 110 mg to prevent blood clot formation after knee or hip replacement surgery. You may be required a lower dose if your kidney function is decreased or if you are 75 years of age or older. For more information, consult your doctor. If you are already taking quinidine, amiodarone, or verapamil medicines, you may receive a lower dose from your doctor because your bleeding risk may be increased. For surgery, treatment should not be started if there is bleeding from the operation site.
After knee replacement surgery, your doctor may ask you to take a single capsule of Dabigatran within 1 to 4 hours after surgery. After that, two capsules once daily needs to be taken for ten days.
After hip replacement surgery, you should begin treatment with a single capsule of Dabigo within 1 to 4 hours of surgery. After that, two capsules are recommended that needs to be taken for 28 to 35 days.
The dosing regimen you will receive from your doctor may be different. So, it is always important to consult a doctor before taking Dabigatran capsules. Your doctor will prescribe a dose that will suit your condition.
What is Dabigatran Etexilate and what condition does it treat?
Dabigatran Etexilate is an oral anticoagulant medication, commonly known as a blood thinner, used to prevent stroke and dangerous blood clots. Dabigo 110mg contains this active ingredient and treats conditions including atrial fibrillation (irregular heartbeat), deep vein thrombosis, and pulmonary embolism. This direct thrombin inhibitor works by reducing the blood's ability to form harmful clots that could block arteries or veins. Patients with non-valvular atrial fibrillation particularly benefit from this clot prevention therapy. Dabigatran Etexilate belongs to the novel oral anticoagulant (NOAC) category, offering an alternative to traditional warfarin therapy for stroke prevention and venous thromboembolism treatment.
How does Dabigatran Etexilate work in the body?
Dabigatran Etexilate functions as a direct thrombin inhibitor, blocking the enzyme responsible for converting fibrinogen into fibrin during blood clot formation. After swallowing Dabigo 110mg capsules, the prodrug is rapidly absorbed and converted into its active form, dabigatran. This anticoagulant specifically targets thrombin, a key protein in the coagulation cascade, preventing excessive clotting without requiring regular blood monitoring like older blood thinners. The medication reaches peak concentration within two hours and maintains predictable anticoagulation effects. By inhibiting thrombin's clotting action, this stroke prevention medication reduces the risk of thromboembolic events while allowing normal hemostasis for minor injuries.
How long does Dabigo 110mg take to work?
Dabigo 110mg containing Dabigatran Etexilate begins working quickly, reaching maximum blood concentration approximately two hours after ingestion. This rapid-acting anticoagulant starts reducing clotting risk within hours of the first dose, though full therapeutic anticoagulation stabilizes after several consecutive doses. For stroke prevention in atrial fibrillation patients, consistent daily use over several days establishes optimal protection. The blood-thinning effect diminishes relatively quickly once stopped, with anticoagulant activity declining significantly within 12 to 24 hours depending on kidney function. This predictable onset and offset make Dabigatran Etexilate convenient for surgical planning compared to traditional anticoagulants requiring longer adjustment periods.
When and how should I take Dabigo 110mg?
Take Dabigo 110mg exactly as prescribed, typically twice daily at approximately the same times each morning and evening to maintain consistent anticoagulation. Swallow the capsule whole with water—do not open, chew, or crush it, as this increases bleeding risk. You can take this Dabigatran Etexilate medication with or without food, though taking it with meals may reduce stomach discomfort for some patients. If you miss a dose and remember within six hours, take it immediately; otherwise, skip it and resume your regular schedule. Never double doses. Always consult your doctor before starting, stopping, or adjusting this blood thinner, as improper use could lead to stroke or dangerous bleeding.
Is Dabigo 110mg safe for long-term use?
Dabigo 110mg is designed for long-term anticoagulation therapy and has demonstrated safety in extended use for chronic conditions like atrial fibrillation. Clinical studies show that Dabigatran Etexilate maintains effective stroke prevention over years of continuous treatment with manageable side effects. This blood thinner requires less monitoring than warfarin, though regular kidney function assessments are recommended since the medication is eliminated through the kidneys. Most patients tolerate prolonged anticoagulant therapy well when properly supervised. Your healthcare provider will periodically evaluate whether continued treatment remains appropriate based on your bleeding risk, kidney health, and ongoing need for clot prevention in your specific cardiovascular condition.
Can I take Dabigo 110mg with other medicines?
Dabigo 110mg can interact with various medications, so disclosure of all medicines, supplements, and herbal products to your doctor is essential. This Dabigatran Etexilate anticoagulant should not be combined with other blood thinners like warfarin, aspirin (except when specifically prescribed), or other anticoagulants due to severe bleeding risk. Medications affecting drug metabolism—including certain antibiotics, antifungals, and seizure medications—can increase or decrease dabigatran levels dangerously. NSAIDs like ibuprofen may increase bleeding risk when taken with this stroke prevention medication. P-glycoprotein inhibitors such as dronedarone or systemic ketoconazole significantly alter dabigatran concentrations. Always verify compatibility before starting new medications while on this blood thinner therapy.
How does Dabigo 110mg compare to similar medicines in its class?
Dabigo 110mg belongs to the direct oral anticoagulant (DOAC) class alongside rivaroxaban, apixaban, and edoxaban, but differs as a direct thrombin inhibitor rather than a Factor Xa inhibitor. Compared to warfarin, Dabigatran Etexilate offers more predictable anticoagulation without regular blood monitoring or dietary restrictions. The 110mg strength provides lower bleeding risk than higher doses while maintaining stroke prevention efficacy, particularly suitable for elderly patients or those with moderate renal impairment. Unlike some anticoagulants requiring once-daily dosing, this blood thinner requires twice-daily administration for consistent effect. Clinical trials show comparable stroke prevention rates to other NOACs, with individual choice depending on kidney function, drug interactions, and patient preference.
Is the generic Dabigatran Etexilate as effective as branded versions?
Generic Dabigatran Etexilate, including Dabigo 110mg, contains the identical active pharmaceutical ingredient as branded Pradaxa and delivers equivalent therapeutic effectiveness for stroke prevention and blood clot treatment. Regulatory authorities worldwide require generic anticoagulants to demonstrate bioequivalence, meaning they produce the same blood levels and clinical effects as original branded versions. The anticoagulant potency, safety profile, and clot prevention capability remain consistent across approved generic and branded formulations. Many patients choose generic versions like Dabigo for significant cost savings while receiving the same quality blood-thinning therapy. All legitimate generic Dabigatran Etexilate products meet stringent manufacturing standards, ensuring reliable anticoagulation for atrial fibrillation and thromboembolism prevention.
Why do patients choose PremiumRxDrugs for Dabigo 110mg?
Patients consistently select PremiumRxDrugs for Dabigo 110mg because our licensed pharmacy combines affordability with authenticity for long-term anticoagulant therapy. The platform offers significantly lower prices on Dabigatran Etexilate compared to local pharmacies, helping patients manage ongoing stroke prevention costs without compromising medication quality. Manufacturer-sourced medicines guarantee genuine blood thinners, critical for a medication where consistency affects safety. Worldwide shipping with discreet packaging ensures privacy and convenience, particularly valuable for patients requiring regular refills of chronic medications. The streamlined reorder system eliminates prescription management hassles. Having served international customers for over ten years, PremiumRxDrugs has built reputation and trust for reliably delivering essential cardiovascular medications like this anticoagulant.
What are the common side effects of Dabigatran Etexilate?
Dabigatran Etexilate commonly causes bleeding-related side effects since this anticoagulant intentionally reduces blood clotting ability. Patients frequently experience minor bleeding such as nosebleeds, bruising more easily, bleeding gums when brushing, or prolonged bleeding from cuts. Gastrointestinal effects including stomach pain, indigestion, nausea, or diarrhea occur in some individuals taking this blood thinner. Some patients notice blood in urine or stools, appearing pink, red, or black. Less commonly, this medication may cause headaches or dizziness. While serious bleeding events are rare, any unusual, prolonged, or heavy bleeding requires immediate medical attention. Most side effects from this stroke prevention medication remain mild and manageable, with benefits typically outweighing risks for appropriate candidates requiring anticoagulation therapy.
Who should avoid taking Dabigatran Etexilate?
Dabigatran Etexilate is unsuitable for individuals with active pathological bleeding, severe kidney impairment, or mechanical heart valves. Patients with prosthetic heart valves should not use this anticoagulant as studies showed increased risks compared to warfarin. Those with known hypersensitivity or allergic reactions to this blood thinner must avoid it. Individuals taking other anticoagulants simultaneously face dangerous bleeding complications. Pregnant women should generally not use this medication due to potential fetal risks, and breastfeeding mothers should discuss alternatives as the drug passes into breast milk. Patients with significantly impaired liver function or those at high bleeding risk from recent surgery, ulcers, or bleeding disorders require careful evaluation before starting this stroke prevention therapy.
Login
Sign Up
Login
Sign Up